Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 212,681 |
|
|||||
| News | - | ||||||
| Day High | 8.21 | Low High |
|||||
| Day Low | 7.75 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CVRx Inc | CVRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.34 | 4.40% | 8.06 | 16:29:57 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.79 | 7.75 | 8.21 | 8.06 | 7.72 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,828 | 212,681 | $ 8.03 | $ 1,707,223 | - | 7.06 - 33.135 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:39:05 | 50 | $ 8.22 | USD |
CVRx Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 168.68M | 20.93M | - | 39.3M | -41.2M | -1.97 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CVRx News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CVRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.10 | 8.21 | 7.06 | 7.57 | 293,858 | -0.04 | -0.49% |
| 1 Month | 16.45 | 16.65 | 7.06 | 9.84 | 345,350 | -8.39 | -51.00% |
| 3 Months | 22.00 | 22.86 | 7.06 | 14.03 | 204,922 | -13.94 | -63.36% |
| 6 Months | 18.94 | 33.135 | 7.06 | 19.49 | 182,943 | -10.88 | -57.44% |
| 1 Year | 12.35 | 33.135 | 7.06 | 17.70 | 152,392 | -4.29 | -34.74% |
| 3 Years | 26.25 | 33.135 | 4.60 | 14.10 | 142,656 | -18.19 | -69.30% |
| 5 Years | 26.25 | 33.135 | 4.60 | 14.10 | 142,656 | -18.19 | -69.30% |
CVRx Description
| CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. |
